Lithium Dosing and Serum Concentrations Across the Age Spectrum: From Early Adulthood to the Tenth Decade of Life

Drugs and Aging

Volumn 31, Issue 12, 2014, Pages 911-916

  Rej, Soham ^a   Beaulieu, Serge ^a   Segal, Marilyn ^a   Low, Nancy C P ^a   Mucsi, Istvan ^a   Holcroft, Christina ^b   Shulman, Kenneth ^c   Looper, Karl J ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Biostatistician   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; TRANQUILIZER;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CROSS-SECTIONAL STUDY; DOSAGE SCHEDULE COMPARISON; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LITHIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; URINALYSIS; VERY ELDERLY; AGING; BLOOD; DOSE RESPONSE; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIMANIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LITHIUM; MIDDLE AGED;

EID: 84911974441     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-014-0221-1     Document Type: Article

References (23)

1. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013;15(1):1–44. doi:10.1111/bdi.12025.
2. Hopkins HS, Gelenberg AJ. Serum lithium levels and the outcome of maintenance therapy of bipolar disorder. Bipolar Disord. 2000;2(3 Pt 1):174–9.
3. Rej S, Herrmann N, Shulman K. The effects of lithium on renal function in older adults–a systematic review. J Geriatr Psychiatry Neurol. 2012;25(1):51–61. doi:10.1177/0891988712436690.
4. Al Jurdi RK, Marangell LB, Petersen NJ, Martinez M, Gyulai L, Sajatovic M. Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a “recovered” status in the systematic treatment enhancement program for bipolar disorder. Am J Geriatr Psychiatry. 2008;16(11):922–33. doi:10.1097/JGP.0b013e318187135f.
5. Rej S, Looper K, Segal M. The effect of serum lithium levels on renal function in geriatric outpatients: a retrospective longitudinal study. Drugs Aging. 2013. doi:10.1007/s40266-013-0068-x.
6. Wijeratne C, Draper B. Reformulation of current recommendations for target serum lithium concentration according to clinical indication, age and physical comorbidity. Aust N Z J Psychiatry. 2011;45(12):1026–32. doi:10.3109/00048674.2011.610296.
7. Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging. 2000;16(3):165–77.
8. Eastham JH, Jeste DV, Young RC. Assessment and treatment of bipolar disorder in the elderly. Drugs Aging. 1998;12(3):205–24.
9. Hewick DS, Newbury P, Hopwood S, Naylor G, Moody J. Age as a factor affecting lithium therapy. Br J Clin Pharmacol. 1977;4(2):201–5.
10. Slater V, Milanes F, Talcott V, Okafor KC (1984) Influence of age on lithium therapy. South Med J 77 (2):153–154, 158.
11. Vestergaard P, Schou M. The effect of age on lithium dosage requirements. Pharmacopsychiatry. 1984;17(6):199–201. doi:10.1055/s-2007-1017438.
12. Greil W, Stoltzenburg MC, Mairhofer ML, Haag M. Lithium dosage in the elderly. A study with matched age groups. J Affect Disord. 1985;9(1):1–4.
13. Coppen A, Abou-Saleh MT. Lithium therapy: from clinical trials to practical management. Acta Psychiatr Scand. 1988;78(6):754–62.
14. Singh LK, Nizamie SH, Akhtar S, Praharaj SK. Improving tolerability of lithium with a once-daily dosing schedule. Am J Ther. 2011;18(4):288–91. doi:10.1097/MJT.0b013e3181d070c3.
15. Rej S, Segal M, Low NC, Mucsi I, Holcroft C, Shulman K, Looper K. The McGill Geriatric Lithium-Induced Diabetes Insipidus Clinical Study (McGLIDICS). Can J Psychiatry. 2014;59(6):327–34.
16. Weinstein JR, Anderson S. The aging kidney: physiological changes. Adv Chronic Kidney Dis. 2010;17(4):302–7. doi:10.1053/j.ackd.2010.05.002.
17. Head L, Dening T. Lithium in the over-65s: who is taking it and who is monitoring it? A survey of older adults on lithium in the Cambridge Mental Health Services catchment area. Int J Geriatr Psychiatry. 1998;13(3):164–71.
18. Fahy S, Lawlor BA. Discontinuation of lithium augmentation in an elderly cohort. Int J Geriatr Psychiatry. 2001;16(10):1004–9.
19. Ross J. Discontinuation of lithium augmentation in geriatric patients with unipolar depression: a systematic review. Can J Psychiatry. 2008;53(2):117–20.
20. Jensen HV, Plenge P, Stensgaard A, Mellerup ET, Thomsen C, Aggernaes H, Henriksen O. Twelve-hour brain lithium concentration in lithium maintenance treatment of manic-depressive disorder: daily versus alternate-day dosing schedule. Psychopharmacology (Berl). 1996;124(3):275–8.
21. Young RC, Schulberg HC, Gildengers AG, Sajatovic M, Mulsant BH, Gyulai L, et al. Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD. Bipolar Disord. 2010;12(1):56–67. doi:10.1111/j.1399-5618.2009.00779.x.
22. Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry. 2008;65(9):1017–32. doi:10.1001/archpsyc.65.9.1017.
23. Collins N, Barnes TR, Shingleton-Smith A, Gerrett D, Paton C. Standards of lithium monitoring in mental health trusts in the UK. BMC Psychiatry. 2010;10:80. doi:10.1186/1471-244X-10-80.